Phase II study evaluating ipilimumab as a single agent in the first-line treatment of adult patients (Pts) with metastatic uveal melanoma (MUM): The GEM-1 trial.
Jose Maria Piulats Rodriguez
No relevant relationships to disclose
Maria Ochoa de Olza
No relevant relationships to disclose
Manuel Codes
No relevant relationships to disclose
Jose A. Lopez-Martin
No relevant relationships to disclose
Alfonso Berrocal
No relevant relationships to disclose
Margarita GarcĂa
No relevant relationships to disclose
Alfonso Gurpide
No relevant relationships to disclose
Blanca Homet
No relevant relationships to disclose
Salvador Martin-Algarra
No relevant relationships to disclose